Mirion Technologies Q1 revenue beats estimates

Mirion Technologies

28/04/2026 21:29

Overview

US radiation detection firm's Q1 revenue rose 27.5%, beating analyst expectations

Adjusted EPS for Q1 was flat at $0.10

Company reaffirmed 2026 revenue and EBITDA guidance, but lowered adjusted EPS outlook

Outlook

Mirion reaffirms 2026 revenue growth guidance of 22.0%–24.0%

Company revises 2026 adjusted EPS guidance to $0.48–$0.55 from $0.50–$0.57

Mirion expects continued momentum in nuclear power and cancer care markets in 2026

Result Drivers

NUCLEAR POWER DEMAND - Co said record capital spending by power plant operators drove strong orders and revenue growth

ACQUISITION CONTRIBUTIONS - Paragon acquisition contributed to revenue and orders growth; integration on track and commercial synergies being realized

CANCER CARE AND NEW PRODUCTS - Co said it is capturing momentum in Cancer Care markets and bringing new products to market

Company press release: ID:nBw2P6QWTa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$257.6 mln
$244.78 mln (8 Analysts)
Q1 EPS
-$0.01
Q1 Net Income
-$3.4 mln
Q1 EBIT
$3.7 mln
Q1 Gross Profit
$119.1 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

Wall Street's median 12-month price target for Mirion Technologies Inc is $29.00, about 50.6% above its April 27 closing price of $19.25

The stock recently traded at 33 times the next 12-month earnings vs. a P/E of 39 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)